Our Mission

IP Compass was founded by a team of Law Students with technology background who recognized a critical gap in the pharmaceutical innovation lifecycle. For too long, the process of challenging invalid patents has been opaque, costly, and inefficient, creating significant barriers to market entry for generic and biosimilar developers.

Our mission is twofold: to provide a strategic asymmetric advantage to our commercial partners through powerful AI-driven prior art analysis, and to democratize access to innovation by offering our tools to academics, students, and inventors in developing nations.

We believe that by combining deep legal expertise with cutting-edge artificial intelligence, we can create a more equitable and efficient patent system for everyone.